Key result
SAPS3 demonstrated excellent discrimination for predicting hospital mortality (AUC 0.916), similar to APACHE II (AUC 0.893) and SOFA (AUC 0.846), but with better calibration than APACHE II.
Why the study?
Does SAPS3 accurately predict hospital mortality compared to APACHE II and SOFA in adult ICU patients in Southern Europe?
Cohort (n=864)
No
Does SAPS3 accurately predict hospital mortality compared to APACHE II and SOFA in adult ICU patients in Southern Europe?
Effect estimate: AUC 0.916
SAPS3 customized for Southern Europe accurately predicts hospital mortality risk in a mixed-case ICU, demonstrating better calibration than APACHE II.
No takes yet. Share an insight, caveat, or question.
SAPS3 may aid mortality prediction in Southern European ICUs; extends prior comparisons but leaves generalizability open.
Mbongo et al. (2009) conducted a cohort in Adult patients in a mixed intensive care unit (n=864). SAPS3 vs. APACHE II and SOFA was evaluated on Hospital mortality prediction (discrimination and calibration) (AUC 0.916). SAPS3 demonstrated excellent discrimination for predicting hospital mortality (AUC 0.916), similar to APACHE II (AUC 0.893) and SOFA (AUC 0.846), but with better calibration than APACHE II.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: